Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Baxter
Johnson and Johnson
McKesson

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Patents Expiring in September 2033

➤ Subscribe for complete access

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-001 Dec 22, 2015 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER AFTER FAILURE OF PRIOR PLATINUM-BASED CHEMOTHERAPY
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-001 Dec 22, 2015 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK IN COMBINATION WITH CISPLATIN AND FLUOROURACIL
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-001 Dec 22, 2015 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free USE IN COMBINATION WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR ADJUVANT TREATMENT OF PATIENTS WITH OPERABLE NODE-POSITIVE BREAST CANCER
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-001 Dec 22, 2015 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free TREATMENT OF PATIENTS WITH LOCALLY ADVANCED METASTATIC BREAST CANCER AFTER FAILURE OF PRIOR CHEMOTHERAPY
Shilpa DOCETAXEL docetaxel INJECTABLE;INJECTION 205934-001 Dec 22, 2015 AP RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y METHOD OF ADMINISTERING AN ETHANOL-FREE TAXANE LIQUID NANODISPERSION FORMULATION TO A SUBJECT COMBINING THE FORMULATION WITH AN AQUEOUS MEDIUM TO PROVIDE AN ETHANOL-FREE TAXANE DILUTED SOLUTION
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKesson
Harvard Business School
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.